Table 1 Comparison laboratory parameters between mild and severe patients infected with COVID-19

Mean age ± SD

53.7 ± 11.7

61.2 ± 12.8

54.2 ± 12.1

Gender (male/female)

108/80 (57.4/42.6%)

66/76 (46.5/53.5%)

82/78 (51.2/48.8%)

ALT, IU/L (mean ± SD) (Reference range: 5–40)

29.7 ± 19.1

32.5 ± 20.3

29.5 ± 20.4

AST, IU/L (mean ± SD) (Reference range: 5–40)

31.1 ± 16.9

34.6 ± 19.7

28.6 ± 16.7

ALP, IU/L (mean ± SD) (Reference range: up to 306)

180.4 ± 98.9

172.8 ± 82.6

212.8 ± 99.6

Cholesterol, mg/dL (mean ± SD) (Reference range: 50–200)

171.9 ± 53.9

109.1 ± 29.4

167.9 ± 49.8

TG, mg/dL (mean ± SD) (Reference range: 60–165)

173.1 ± 62.4

125.9 ± 63.4

162.1 ± 58.4

LDL, mg/dL (mean ± SD) (Reference range: up to 150)

125.1 ± 49.1

56.4 ± 19.3

110.5 ± 28.7

HDL, mg/dL (mean ± SD) (Reference range: >40)

31.0 ± 12.1

33.1 ± 12.9

39.1 ± 13.1

WBC, 10⁹/L (mean ± SD) (Reference range: 4000–10,000)

7443.6 ± 2524.5

7823.1 ± 2906.9

6842.1 ± 2102.1

CRP, mg/L (mean ± SD) (Reference range: <10 mg/L Negative)

58.8 ± 21.5

74.3 ± 14.9

9.3 ± 2.9

ESR, mm/1st h (mean ± SD) (Reference range: 0–15)

51.0 ± 17.4

61.5 ± 12.4

11.5 ± 4.7

FBS, mg/dL (mean ± SD) (Reference range: 70–100)

103.5 ± 40.0

102.5 ± 30.1

99.5 ± 28.2

Platelets × 1000/cumm (mean ± SD) (Reference range: 140,000–400,000)

179 ± 67

188 ± 84

185 ± 81

T3, ng/dL (mean ± SD) (Reference range: 2.3–4.2)

2.4 ± 1.3

1.7 ± 0.9

2.1 ± 1.1

T4, mcg/dL (mean ± SD) (Reference range: 5.6–13.7)

8.6 ± 7.1

9.9 ± 7.2

10.1 ± 7.9

TSH, mu/L (mean ± SD) (Reference range: 0.4–4.5)

3.1 ± 1.7

3.3 ± 1.8

2.8 ± 1.1

Hemoglobin, g/dL (mean ± SD) (Reference range: 12–18)

13.1 ± 2.5

12.2 ± 1.7

14.2 ± 2.7

BUN, mg/dL (mean ± SD) (Reference range: 15–45)

38.1 ± 7.1

36.9 ± 6.9

32.1 ± 5.9

Creatinine, mg/dL (mean ± SD) (Reference range: 0.6–1.4)

1.1 ± 0.6

1.0 ± 0.4

1.2 ± 0.7

25-hydroxy vitamin D, ng/mL (mean ± SD) (Sufficiency: 21–150)

34.7 ± 13.8

19.1 ± 9.7

31.2 ± 11.7

Real-time PCR Ct values

28.8 ± 8.9

12.8 ± 7.4

-